IBD at the End of its First Century
Herausgegeben:Rogler, G.; Kullman, F.; Rutgeerts, P.; Sartor, R. B.; Schölmerich, J.
IBD at the End of its First Century
Herausgegeben:Rogler, G.; Kullman, F.; Rutgeerts, P.; Sartor, R. B.; Schölmerich, J.
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Although the first description of patients with what we now call Crohn's disease or ulcerative colitis was published well before 1900, both disorders seem to be diseases of the twentieth century. At the very start of the twenty-first century, it therefore seems appropriate to look back and at the same time look forward and to assess what knowledge has been gained during the last 100 years and in what direction research and thereby clinical practice will go in the future. This book, the proceedings of Falk Symposium No. 111 held in Freiburg, Germany, on June 19-20 1999, contains contributions…mehr
- H.-J. Krammer / M.V. Singer (Hgg.)Neurogastroenterology - From the Basics to the Clinics231,99 €
- Harold KalterTeratology in the Twentieth Century Plus Ten110,99 €
- New Trends in Cancer for the 21st Century147,99 €
- R.J. Groszmann / J. Bosch (Hgg.)Portal Hypertension in the 21st Century180,99 €
- Portal Hypertension in the 21st Century116,99 €
- Human Nutrition from the Gastroenterologist¿s Perspective37,99 €
- I.W. Fong / Karl Drlica (Hgg.)Reemergence of Established Pathogens in the 21st Century116,99 €
-
-
-
This book, the proceedings of Falk Symposium No. 111 held in Freiburg, Germany, on June 19-20 1999, contains contributions from experienced senior scientists on the state of the art in pathophysiology, diagnosis and treatment, together with unpublished and new findings from young researchers. Basic scientists and clinicians are thereby involved in an exchange of information which will lead to new directions for future research and clinical management of inflammatory bowel diseases.
- Produktdetails
- Falk Symposium 111
- Verlag: Springer / Springer Netherlands
- Artikelnr. des Verlages: 978-0-7923-8756-5
- 2000.
- Seitenzahl: 344
- Erscheinungstermin: 31. Juli 2000
- Englisch
- Abmessung: 241mm x 160mm x 24mm
- Gewicht: 658g
- ISBN-13: 9780792387565
- ISBN-10: 0792387562
- Artikelnr.: 23338417
- Falk Symposium 111
- Verlag: Springer / Springer Netherlands
- Artikelnr. des Verlages: 978-0-7923-8756-5
- 2000.
- Seitenzahl: 344
- Erscheinungstermin: 31. Juli 2000
- Englisch
- Abmessung: 241mm x 160mm x 24mm
- Gewicht: 658g
- ISBN-13: 9780792387565
- ISBN-10: 0792387562
- Artikelnr.: 23338417
Genes for IBD; D. van Heel, et al. 2. Interleukin-1 Beta Gene Polymorphisms
as Genetic Markers in Perforating and Non-Perforating Crohn's Disease; A.
Nemetz, et al. 3. Genetic Determination and Susceptibility: Future Aspects;
R.H. Duerr. 4. Interactions Between Enteric Bacteria and the Immune System
Which Determine Mucosal Homeostasis vs. Chronic Intestinal Inflammation:
Lessons from Rodent Models; R.B. Sartor, C. Veltkamp. 5. Gut Flora: Future
Implications; R. Duchmann. 6. Response and Non-Response in the Mucosal
Immune System; W. Strober, et al. 7. Immunotherapeutic Approaches in
Inflammatory Bowel Diseases; M.F. Neurath, et al. 8. Intestinal Epithelial
Barrier Dysfunction; S.V. Sitaraman, et al. 9. IL-10 Inhibits NF-kB by
Distinct Mechanisms; A.J.G. Schottelius, et al. 10. Future Ways to Study
Epithelial Cell Functions; G. Rogler. 11. Regulation of Intestinal Crypt
Cell Apoptosis in the Murine Acute Graft-versus-Host Disease; E. Stüber, et
al. 12. Apoptosis and Mucosal Lymphocytes: Defective Mucosal Lymphocyte
Apoptosis is Associated with Inflammation; M. Boirivant, et al. 13.
Regulation of Intestinal Epithelial Wound Healing; M.N. Göke, D.K.
Podolsky. 14. Myofibroblasts and Epithelial Repair in the Intestinal
Mucosa; M.N. Göke, D.K. Podolsky. 15. Etiopathogenesis 1999 - How to Put it
All Together; C.O. Elson, et al. Section II: Clinical Approach and
Treatment. 16. The Influence of 20th Century Biomedical Thought on the
Origins of IBD Therapy; J.B. Kirsner. 17. Differentiation and Subgrouping
of IBD: State of the Art; P. Rugeerts, et al. 18. Differentiation and
Subgrouping of Crohn's Disease; G. Rocca, et al. 19. Do Subgroups of
Crohn's Disease Matter for Future Patient Care? C. Gasche. 20. Treatment of
Active, Severe and Refractory Ulcerative Colitis: State of the Art; S.B.
Hanauer. 21. Treatment of active, severe and refractory ulcerative colitis:
new therapeutic approaches, unpublished data; H. Herfarth. 22. Cyclosporin
for Corticosteroid-Refractory Ulcerative Colitis. Refinement of Current
Treatment Modalities; G.C. Actis, et al. 23. Two Decades of Restorative
Proctocolectomy: Laudation or Requiem for the Ileoanal Pouch Procedure? C.
Herfarth, et al. 24. Risk of Dysplasia in Long-Term Ileal Pouches or
Pouches with Chronic Pouchitis; M. Thompson-Fawcett. 25. Improving the
Long-Term Outcome of Surgery: The Future; R.S. McLeod. 26. Azathioprine
Metabolism in IBD: Correlation with Efficacy and Toxicity; C. Cuffari. 27.
Steriod Dependent and Refradctory Disease: State of the Art; D.H. Present.
28. Thalidomide Therapy: History, Pharmacology and Consideration as a
Treatment for Crohn's Disease; E.D. Ehrenpreis, et al. 29. Maintenance of
Remission in Ulcerative Colitis and Crohn's Disease; L.R. Sutherland. 30.
Remission Maintenance in UC and CD: Unpublished Data; P. Gionchetti, et al.
31. Experimental Treatments in IBD &endash; Are Too Many and Do We Have the
Right Targets? J. Schölmerich. 32. Patient Education in Patients with
Inflammatory Bowel Disease; N. Bregenzer, et al. 33. Supportive Care in
Inflammatory Bowel Disease; E.J. Irvine. 34. How to Put it All together
&endash; Visions for the Second Century; W.J. Sandborn. Index.
Genes for IBD; D. van Heel, et al. 2. Interleukin-1 Beta Gene Polymorphisms
as Genetic Markers in Perforating and Non-Perforating Crohn's Disease; A.
Nemetz, et al. 3. Genetic Determination and Susceptibility: Future Aspects;
R.H. Duerr. 4. Interactions Between Enteric Bacteria and the Immune System
Which Determine Mucosal Homeostasis vs. Chronic Intestinal Inflammation:
Lessons from Rodent Models; R.B. Sartor, C. Veltkamp. 5. Gut Flora: Future
Implications; R. Duchmann. 6. Response and Non-Response in the Mucosal
Immune System; W. Strober, et al. 7. Immunotherapeutic Approaches in
Inflammatory Bowel Diseases; M.F. Neurath, et al. 8. Intestinal Epithelial
Barrier Dysfunction; S.V. Sitaraman, et al. 9. IL-10 Inhibits NF-kB by
Distinct Mechanisms; A.J.G. Schottelius, et al. 10. Future Ways to Study
Epithelial Cell Functions; G. Rogler. 11. Regulation of Intestinal Crypt
Cell Apoptosis in the Murine Acute Graft-versus-Host Disease; E. Stüber, et
al. 12. Apoptosis and Mucosal Lymphocytes: Defective Mucosal Lymphocyte
Apoptosis is Associated with Inflammation; M. Boirivant, et al. 13.
Regulation of Intestinal Epithelial Wound Healing; M.N. Göke, D.K.
Podolsky. 14. Myofibroblasts and Epithelial Repair in the Intestinal
Mucosa; M.N. Göke, D.K. Podolsky. 15. Etiopathogenesis 1999 - How to Put it
All Together; C.O. Elson, et al. Section II: Clinical Approach and
Treatment. 16. The Influence of 20th Century Biomedical Thought on the
Origins of IBD Therapy; J.B. Kirsner. 17. Differentiation and Subgrouping
of IBD: State of the Art; P. Rugeerts, et al. 18. Differentiation and
Subgrouping of Crohn's Disease; G. Rocca, et al. 19. Do Subgroups of
Crohn's Disease Matter for Future Patient Care? C. Gasche. 20. Treatment of
Active, Severe and Refractory Ulcerative Colitis: State of the Art; S.B.
Hanauer. 21. Treatment of active, severe and refractory ulcerative colitis:
new therapeutic approaches, unpublished data; H. Herfarth. 22. Cyclosporin
for Corticosteroid-Refractory Ulcerative Colitis. Refinement of Current
Treatment Modalities; G.C. Actis, et al. 23. Two Decades of Restorative
Proctocolectomy: Laudation or Requiem for the Ileoanal Pouch Procedure? C.
Herfarth, et al. 24. Risk of Dysplasia in Long-Term Ileal Pouches or
Pouches with Chronic Pouchitis; M. Thompson-Fawcett. 25. Improving the
Long-Term Outcome of Surgery: The Future; R.S. McLeod. 26. Azathioprine
Metabolism in IBD: Correlation with Efficacy and Toxicity; C. Cuffari. 27.
Steriod Dependent and Refradctory Disease: State of the Art; D.H. Present.
28. Thalidomide Therapy: History, Pharmacology and Consideration as a
Treatment for Crohn's Disease; E.D. Ehrenpreis, et al. 29. Maintenance of
Remission in Ulcerative Colitis and Crohn's Disease; L.R. Sutherland. 30.
Remission Maintenance in UC and CD: Unpublished Data; P. Gionchetti, et al.
31. Experimental Treatments in IBD &endash; Are Too Many and Do We Have the
Right Targets? J. Schölmerich. 32. Patient Education in Patients with
Inflammatory Bowel Disease; N. Bregenzer, et al. 33. Supportive Care in
Inflammatory Bowel Disease; E.J. Irvine. 34. How to Put it All together
&endash; Visions for the Second Century; W.J. Sandborn. Index.